Consultancy

TERMS OF REFERENCE


FOR SHORT TERM CONSULTANCY SERVICES TO SUPPORT THE MBARARA AND NTUNGAMO DISTRICT – BASED PEDIATRIC TB CSO ADVOCACY GROUPS DEVELOP POSITION PAPERS AND ADVOCACY BRIEFS WITH ISSUES ON PEDIATRIC TB

BACKGROUND

Uganda is one of the 30 high TB burden countries, with an incidence of 200/100,000 population. The incidence level has been virtually stagnant for the last 18 years.  In 2018, there were an estimated 86,000 TB cases in the country, but only 55,835 cases were notified, while 35% were missed. The national prevalence survey showed that the ratio of TB among men and women was 4.2:1 and TB is high in the age groups 15-44 years. MDR-TB incidence is also high, 1% for newly diagnosed and 12% for previously treated TB cases. The country was able to detect only 516 MDR-TB patients out of the estimated 1,500 cases in 2018. The HIV positive TB incidence is at about 81/100,000 and the mortality is 25/100,000 population. The Treatment Success Rate (TSR) for the 2017 cohorts was 72%, well below the global recommendation of 85%. For MDR-TB the TSR was 64.2%. Moreover, the TB program is underfunded with a 39% funding gap, in 2018 with only 5% from domestic sources. The HIV prevalence is estimated to be 6.2% and the incidence is 0.4%. It is these adults that transmit TB infection to children less than 5 years, however, only 7.1% of the estimated child Tuberculosis cases were notified to Tuberculosis programs pointing to massive under diagnosis in 2017. More than 67,000,000 healthy children have latent TB infection and are risk of developing the disease in future and less than 300,000 eligible children under 5 were initiated on preventive therapy in 2017

Mbarara Region: During FY2019, 4,697 TB patients were enrolled on TB treatment in Mbarara, 75% registered a Treatment Success Rate. 59%[1] TB testers had access to GeneXpert services; 8% were lost to follow up; 1.1% failed to complete treatment, 10% died, while 5% were not evaluated (2019 NTLP Report). 100% Contact tracing was registered, while 34 Rifampicin Resistant TB cases initiated on treatment by second-line treatment. Most significantly, 85% of PLHIV diagnosed with TB were started on TB treatment. In 2020, there are 1,616 (151%) new TB cases identified. The annual TPT is 12,551 and 2,191 children are initiated on TPT. For the period Oct 2018 to Sept 2019, 110 pediatric TB cases were identified in Mbarara of which 83 registered treatment success. For Oct 2018 to Sept 2019, Ntungamo District registered 30 pediatric TB cases identified of which 23 registered treatment success and a total of 89,310 children under 5 was initiated on IPT.

It is against this background that ADS Information Centre (AIC) in partnership with Elizabeth Glaser Pediatric Foundation (EGPAF) proposes services of a short-term consultant to support the 2 district-based Pediatric TB CSO Advocacy Groups to develop 2 Position Papers and 2 Advocacy Briefs on Paediatric TB in Mbarara and Ntungamo.

GOAL

Two district-based Pediatric TB CSO Advocacy Groups in Mbarara and Ntungamo with Position Papers and Advocacy Briefs on Paediatric TB by 5th February 2021

 

KEY TASKS 

The TA will:

  1. Line list documents to be reviewed in the area of Pediatric TB and specifically Pediatric TB in Mbarara and Ntungamo districts
  2. Make an analysis of the above listed documents
  3. Develop Position Papers for Mbarara and Ntungamo
  4. Develop Advocacy briefs for Mbarara and Ntungamo
  5. Present the respective Position Papers and Advocacy Briefs to the Advocacy Groups of Mbarara and Ntungamo to have consensus and approval

 

DELIVERABLES

  1. An inception report detailing how the assignment will be executed
  2. 02 Position Papers developed and adopted by the Advocacy Groups
  3. 02 Advocacy briefs developed and adopted by the Advocacy Group3. Activity report

 

PROPOSED TIME LINE

The exercise will be conducted over a period of 7 working days

PAYMENT

The TA will be paid 100% of the total amount after development and approval of the Position Papers and Advocacy briefs by the Advocacy Groups

SPECIFICATIONS OF CONSULTANT

The consultant should have experience in Health Systems Strengthening with a bias to TB and HIV programming and demonstrable experience in managing HIV/TB integration programming at policy and implementation level. They should have also have experience in implementation of an advocacy project and working with the MoH and District local governments.

 

APPLICATION PROCEDURE AND SUBMISSION OF OFFER

All interested Applicants that meet the requirements should send their Expression of Interest (EOIs) for their understanding of the assignment which should include the following:

  • A proposal detailing how the assignment will be executed.
  • Individual profile reflecting previous experience

 

QUALIFICATIONS

At least a Degree with relevance to Health and Advocacy.

SUBMISSION DEADLINE

Expressions of Interests should be submitted to the Chairperson Procurement Committee at procurementcommittee@aicug.org by close of business Monday 11th January 2021 by 5:00pm.